Replies to post #298361 on Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

When I say I’m long, I mean loooooooong.

I've said before I have the first tranche of shares for sale at $3 and a second tranche for sale at $5, but I will hold the vast majority of my shares for buyout. My oldest kids are in 7th grade. I'd like to see the proceeds from at least one of those two tranches of shares sometime prior to the two little weasels hitting college at the same time, but I still make monthly contributions to their 529 accounts, just in case.

[The ELTP King]

That would be the dumbest thing Nasrat could possibly do.

Those companies are competing against the ER branded market of which Purdue owns.

Elite is going after the IR ADT MARKET and the GENERIC ADT MARKET of which there is ZERO competition.

Context is everything.

SequestOx: IR ADT market, no competition

ELI-201: Generic ADT market, no competition

Elite will be the Purdue of these markets.

Nasrat may be smart to follow the lead of these 4 companies who have 5 approved ADF products collecting dust. If these companies aren’t even bothering to launch products they spent millions to develop, then why the hell should we dilute our positions at the worst possible time in order to hurry up SequestOx?

[Jimmy Joe]

Agree with part of your post.

Grow the company with a combination of NDA’s and lucrative ANDA’s. File, file, file. Wait, wait, wait. Launch, launch, launch. Grow, grow, grow. Repeat, repeat, repeat. There is no way to speed up the process.

Part I do not agree with is SequestOx. NH already doing what you prescribe. Going forward with Elite/SunGen ANDAs. Now the wait for FDA
to respond. Does it take this long to access pilot study data? Nope. Does not. So what is taking the FDA so long?
Should be an answer soon IMO.

So NH changing course or insuring by diversifying and additive to total? That's right. Smart move on his part. Confucius say "Never put eggs in one basket. More eggs better chances some eggs not break".


So now suddenly NH is scrapping SequestOx? Or in massive delay?

Whatever you say Doc. Whatever you say.

[The ELTP King]

That strategy doesn't work, has not worked, and will not work.

2 ANDA approvals and revenue increase reported within 6 weeks.

Result: 1.5-2 cent rise in PPS.

Revenue won't rise substantially for at least 3-5 years.

In fact, revenue will DECREASE over the next 6 months due to methadone lapse and Epic's generic lapse.

Also, the filings and ANDA approvals will do little to the PPS.

So if Elite does nothing with SequestOx for the next 1-2 years, I hope everyone enjoys a .10-.15 stock price for those 1-2 years.

COMPLETE THE SEQUESTOX TRIALS AND FILE ASAP!!!!!!!!!!!!!!

Why do I care if SequestOx is approved next year or the year after? I’ll say it again- my enemy is not time, my enemy is dilution. Fine by me to shift the cost of SequestOx back until it can be offset by revenue instead of dilution, especially with recent share price, and especially with the current ADF environment.